120 related articles for article (PubMed ID: 15289727)
21. Absence of thoracic radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for Stage III nonsmall-cell lung cancer.
Jeremic B; Shibamoto Y; Milicic B; Acimovic L; Milisavljevic S
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):343-6. PubMed ID: 9457819
[TBL] [Abstract][Full Text] [Related]
22. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer.
Jeremic B; Jevremovic S; Mijatovic L; Milisavljevic S
Cancer; 1993 Jun; 71(11):3732-6. PubMed ID: 8387885
[TBL] [Abstract][Full Text] [Related]
23. Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study.
Jeremic B; Shibamoto Y; Milicic B; Nikolic N; Dagovic A; Milisavljevic S
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1091-6. PubMed ID: 9869234
[TBL] [Abstract][Full Text] [Related]
24. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
[TBL] [Abstract][Full Text] [Related]
25. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.
Jeremic B; Shibamoto Y; Acimovic L; Milisavljevic S
J Clin Oncol; 1997 Mar; 15(3):893-900. PubMed ID: 9060525
[TBL] [Abstract][Full Text] [Related]
26. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
Komaki R; Seiferheld W; Ettinger D; Lee JS; Movsas B; Sause W
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):548-57. PubMed ID: 12062596
[TBL] [Abstract][Full Text] [Related]
27. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
[TBL] [Abstract][Full Text] [Related]
28. Accelerated hyperfractionated radiotherapy combined with induction and concomitant chemotherapy for inoperable non-small-cell lung cancer--impact of total treatment time.
Nyman J; Bergman B; Mercke C
Acta Oncol; 1998; 37(6):539-45. PubMed ID: 9860311
[TBL] [Abstract][Full Text] [Related]
29. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Marks LB; Garst J; Socinski MA; Sibley G; Blackstock AW; Herndon JE; Zhou S; Shafman T; Tisch A; Clough R; Yu X; Turrisi A; Anscher M; Crawford J; Rosenman J;
J Clin Oncol; 2004 Nov; 22(21):4329-40. PubMed ID: 15514374
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
Lee SW; Choi EK; Lee JS; Lee SD; Suh C; Kim SW; Kim WS; Ahn SD; Yi BY; Kim JH; Noh YJ; Kim SS; Koh Y; Kim DS; Kim WD
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):996-1004. PubMed ID: 12829135
[TBL] [Abstract][Full Text] [Related]
31. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
[TBL] [Abstract][Full Text] [Related]
32. Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone.
Jeremic B; Shibamoto Y; Milicic B; Dagovic A; Nikolic N; Aleksandrovic J; Acimovic L; Milisavljevic S
Lung Cancer; 2003 Jun; 40(3):317-23. PubMed ID: 12781431
[TBL] [Abstract][Full Text] [Related]
33. Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients.
Jeremić B; Miličić B; Milisavljevic S
Cancer; 2011 Jul; 117(13):2995-3003. PubMed ID: 21692056
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
35. [Clinical efficacy of concurrent carboplatin, etoposide, and definitive radiotherapy for stage III non-small-cell lung cancer: consideration as to therapeutic outcomes and morbidity].
Kodaira T; Yamakawa K; Taniguchi H; Matsubara K; Ishigaki T
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Aug; 58(9):497-502. PubMed ID: 9778935
[TBL] [Abstract][Full Text] [Related]
36. Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.
Lau DH; Crowley JJ; Gandara DR; Hazuka MB; Albain KS; Leigh B; Fletcher WS; Lanier KS; Keiser WL; Livingston RB
J Clin Oncol; 1998 Sep; 16(9):3078-81. PubMed ID: 9738578
[TBL] [Abstract][Full Text] [Related]
37. No thoracic radiation myelitis after spinal cord dose > or = 50.4 Gy using 1.2. Gy b.i.d. fractionation in patients with Stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy.
Jeremic B; Shibamoto Y; Milicic B; Dagovic A; Aleksandrovic J; Nikolic N; Igrutinovic I
Lung Cancer; 2002 Mar; 35(3):287-92. PubMed ID: 11844603
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung.
Jeremić B; Miličić B; Milisavljević S
Clin Transl Oncol; 2013 Sep; 15(9):747-53. PubMed ID: 23359170
[TBL] [Abstract][Full Text] [Related]
39. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study.
Jeremic B; Shibamoto Y; Nikolic N; Milicic B; Milisavljevic S; Dagovic A; Aleksandrovic J; Radosavljevic-Asic G
J Clin Oncol; 1999 Jul; 17(7):2092-9. PubMed ID: 10561263
[TBL] [Abstract][Full Text] [Related]
40. Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a phase II study.
Jeremic B; Shibamoto Y; Milicic B; Milisavljevic S; Nikolic N; Dagovic A; Radosavljevic-Asic G
Lung Cancer; 1999 Apr; 24(1):1-9. PubMed ID: 10403688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
